HepCalc vs myFibroScan

HepCalc is a collection of liver related calculators, web links, resources, and editable web links and clinical notes. ◆ Unlike most calculators, entry data is preserved between different calculators limiting the need for reentry of data. ◆ Set your own favorite web links ◆ Save clinical notes, clinical "pearls" in a organized fashion ◆ Integrated U.S. - SI units conversion ◆ Each calculator has a related web reference A must have for the clinician/house officer dealing with liver disease. The customizable WebLinks and Clinical Notes sections alone are valuable tools for anyone. Child-Pugh Score MELD (UNOS) -survival data -TIPS recommendations MELD MELD Sodium (UNOS) MELD 3.0/Survival Alcoholic Hepatitis Calculators: - ABIC -Combined: Lille Model +(MELD, Maddrey DF, ABIC) - Glasgow - Lille Model - Lille Model Projection (using day 0 of Rx, calculates decision making for bilirubin values on day 7) - Maddrey Discriminant Function - MELD alcoholic hepatitis score ( Includes survival percentage) Autoimmune Liver Disease Calculators: -Autoimmune hepatitis Score(1999 International AIH Group Report) -Autominnune hepatitis Simplified Score -AIH/PBC overlap (Paris Criteria) -PBC Survival Mayo GLOBE UK-PBC -PSC Survival Fibrosis Calculators: - APRI Fibrosis Score - FAST (Fibroscan™ + AST) Score - FIB4 Fibrosis Score - FORNS Fibrosis Score - HALT-C Cirrhosis Score - NAFLD Fibrosis Score -SAFE Fibrosis Score (Steatosis-associated Fibrosis Estimate) Risk Assessment Calculators: Liver Decompensation - Acute decompensation without ACLF: CLIF-C AD score and mortality -Acute liver failure - transplant free survival at 21 days - Acute on Chronic Liver Failure AARC score and mortality - Acute on Chronic Liver Failure CLIF-C ACLF score and mortality - Acute on Chronic Liver Failure NACSELD 30 day mortality - BE3A Score: Hep C DAA assessment for decompensated cirrhosis - Decompensation Risk - Hep C -TAM Score: 1 yr post transplant survival for ACLF-3 patients HCC Risk Hep B - HCC Risk Hep B: CHUK - HCC Risk Hep B: REACH B - HCC Risk Hep B on Rx (entecavir, tenofovir): PAGE B HCC Risk Hep C - HCC Risk Hep C : HALT-C - HCC Risk in Chronic Liver Disease: GALAD/GALADUS Other Risks -BEA Score: Baseline event anticipation for Hepatitis Deta -Cardiovascular Risk (CAD-LT): CV risk in LT candidates - CAR-OLT: 1 yr risk of cardiovascular event post OLT -Dili Mortality Risk: 6 mos mortality risk and comorbidity burden - Fungal Infection Risk - NACSELD - RUCAM for DILI assessment - Surgical Risk Cirrhosis: post op mortality major surgery -Surgical Risk Cirrhosis: VOCAL-Penn Score Other Calculators: -ANI (differentiate between alcoholic and non-alcoholic steatohepatitis) -Ascites, refractory -estimate ascites to be gained based on serum sodium and time passed -estimate sodium intake based on serum sodium and ascites gained -Body Mass Index - Portopulmonary Hypertension Calculator: - Pulmonary Vascular Resistance Calculator -diagnostic and UNOS transplant Criteria -HCV treatment tracker (calculates dates for end of Rx and SVR) -Mean arterial pressure -Wilson's Disease: EASL scoring system WebLinks: - Hepatology Societies - Hepatology Organizations - Other Resources (i.e. Drug Hepatoxicity, Hepatitis Rx drug interactions, etc) - Custom WebLinks (make your own links for reference, frequently used, etc.) Clinical Notes: - Create a title and store clinical information, pearls, or any other text for quick ready reference in one place - Can cut and paste from other text for ease of entry of your clinical data

FibroScan® is the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is powered by three unique, patented and validated biomarkers, LSM by VCTE™ (Liver Stiffness Measurement) and CAP™ (Controlled Attenuation Parameter) that benefit from a worldwide clinical evidence with over 5300+ peer-reviewed publications and 180+ international guidelines. myFibroScan app is your everyday FibroScan® companion to access Interpretation Guide and FibroScan® based scores in an easy, fast and intuitive way : The Interpretation Guide utilizes data from clinical studies to assist providers in interpreting FibroScan® examination results. Scores enhance FibroScan® liver disease assessment with biological markers. Scores are presented as educational services intended for licensed healthcare professionals. While the scores are about specific medical and healthcare issues, they are not a substitute for/or replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions. • Fast is an aid to identify at risk MASH patients defined as MASH + NAS≥4 + F≥2. Good to excellent performance in cohorts from different clinical settings (MASLD tertiary care unit, screening, bariatric surgery) and geographical origins (USA, Europe, Asia). Several publications advocate the use of Fast. • Agile 3+ is an aid to identify MASLD patients with advanced fibrosis by combining LSM by VCTE™ and routine clinical parameters to reduce the need for liver biopsy. High clinical performances are demonstrated in large external validation cohorts from different geographical origins. • Agile 4 is an aid to early identify MASLD patients with cirrhosis by combining LSM by VCTE™ and routine clinical parameters. It can help the physicians to manage the disease to prevent liver-related complications such as hepatocellular carcinoma. High clinical performances are demonstrated in large external validation cohorts from different geographical origin. MASH Treatment Eligibility Tool to eliminate the Guesswork. This patient management tool embeds treatment recommendations based on the patient’s FibroScan® results and the latest AASLD Guidance.